Exagen surges as Q2 financials exceed expectations indicating sequential growth
JuSun/iStock via Getty Images
- With over a quarter in value added to the company’s market capitalization on above-average volume, the micro-cap stock Exagen (XGN +26.1%
) is on track to end its five-day losing streak after the company’s Q2 2021 financials…
